In trading on Monday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 4.6% on the day. Components of that ETF showing particular strength include shares of Alexion Pharmaceuticals, up about 30.8% and shares of Syros Pharmaceuticals, up about 22
Source: Industry Insights